NextUp: Biopharma Company Engineering T-Cell Receptors to Destroy Cancerous Solid Tumors

The Navy Yard-Based Biopharma Company is on track to file for their drug candidate, afami-cel, for FDA approval next year.

Article from Philly Mag

Life sciences companies sign HQ leases in Chester County as deals begin to pick up

Three life sciences companies have leased space for their headquarters, making long-term commitments to the Philadelphia region.

Article from Philadelphia Business Journal

More Center City office landlords are seeking refuge in lab space conversions

Miller Investment Management is marketing its building on Chestnut Street to attract life sciences companies and fill its pending vacant space.

Article from Philadelphia Business Journal 

Brandywine Realty Trust and Pennsylvania Biotechnology Center Partner on Life Science Incubator within 14-acre $3.5 billion Schuylkill Yards Innovation Neighborhood

B.Labs will further accelerate scientific development in the booming University City, Philadelphia’s Life Science ecosystem based on the model established at Blumberg Institute’s highly successful Pennsylvania Biotechnology Center (PABC).

Article from Business Wire

Carisma Therapeutics announces first patient dosed in landmark clinical study evaluating engineered macrophages in humans

Clinical stage biopharmaceutical company, CARISMA Therapeutics Inc., announced that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, a human epidermal growth factor receptor 2 (HER2) targeted chimeric antigen receptor macrophage (CAR-M).

Article from Carisma Therapeutics

Top 10 Pharm Country Companies to Receive NIH Funding in 2020

The National Institutes of Health (NIH) has provided significant funding for various research institutes, universities and pharmaceutical companies for drug development research.

Article from BioSpace

Philly Biotech Is On It

From our region’s epicenter of discovery, Greater Philadelphia researchers and companies are part of the global race to get a handle on COVID-19, including Biomeme, The Wistar Institute, and the newly formed Penn Center for Research on Coronaviruses and Other Emerging Pathogens (PENNCoV).

Article from The Philadelphia Citizen

Biotech company with U.S. headquarters in Montco raises $130 million in series B

The biotech company Immunocore, with its U.S. headquarters in Montgomery County, announced a $130 million Series B financing round to continue the development of T-cell receptor therapies.

Article from the Philadelphia Business Journal

Penn gene therapy spinout exceeds projections with $216M IPO

Penn Medicine spinout Passage Bio raised $216 million through an initial public offering to support the continued development of clinical trials for gene therapies to treat rare central nervous system disorders – exceeding expectations and proving that cell and gene therapies can thrive in the Greater Philadelphia region.

Article from the Philadelphia Business Journal

Philadelphia gene therapy startup plans $125M IPO

Another life sciences IPO for Greater Philadelphia: Gene therapy startup Passage Bio plans to go public via a $125 million IPO, to continue developing six gene therapy candidates for central nervous system diseases, including dementia.

Article from the Philadelphia Business Journal